Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide
Open Access
- 15 May 2013
- journal article
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (10) , 1510-1520
Abstract
Caveolin-1 (Cav-1) is a critical regulator of tumor progression in a variety of cancers where it has been shown to act as either a tumor suppressor or tumor promoter. In glioblastoma multiforme, it...Keywords
This publication has 55 references indexed in Scilit:
- Higher Expression of Caveolin-1 Inhibits Human Small Cell Lung Cancer (SCLC) Apoptosis In VitroCancer Investigation, 2012
- Expression and clinical significance of multidrug resistance proteins in brain tumorsJournal of Experimental & Clinical Cancer Research, 2010
- Caveolin-1 Regulating the Invasion and Expression of Matrix Metalloproteinase (MMPs) in Pancreatic Carcinoma CellsJournal of Surgical Research, 2010
- Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathwaysAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Caveolin-1 Acts as a Tumor Suppressor by Down-Regulating Epidermal Growth Factor Receptor-Mitogen-Activated Protein Kinase Signaling Pathway in Pancreatic Carcinoma Cell LinesPancreas, 2009
- Genetic Pathways to Primary and Secondary GlioblastomaThe American Journal of Pathology, 2007
- The multiple faces of caveolaeNature Reviews Molecular Cell Biology, 2007
- PIK3CA alterations in primary (de novo) and secondary glioblastomasActa Neuropathologica, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- P‐glycoprotein in blood–brain barrier endothelial cells: interaction and oligomerization with caveolinsJournal of Neurochemistry, 2003